project id: TCGA-READ; case submitter id: TCGA-G5-6641; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 67; days to birth: -24486; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 24486; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 804.0; icd 10 code: C19; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: Not Reported; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.4; longest dimension: 0.9; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-G5-6641-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;